Next Article in Journal
The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158
Previous Article in Journal
Current Debates in the Management of Visceral Artery Aneurysms: Where the Guidelines Collide
Previous Article in Special Issue
Comment on Moshirfar et al. Accuracy of Six Intraocular Lens Power Calculations in Eyes with Axial Lengths Greater than 28.0 mm. J. Clin. Med. 2022, 11, 5947
 
 
Reply

Article Versions Notes

J. Clin. Med. 2023, 12(9), 3268; https://doi.org/10.3390/jcm12093268
Action Date Notes Link
article xml file uploaded 4 May 2023 08:44 CEST Original file -
article xml uploaded. 4 May 2023 08:44 CEST Update https://www.mdpi.com/2077-0383/12/9/3268/xml
article pdf uploaded. 4 May 2023 08:44 CEST Version of Record https://www.mdpi.com/2077-0383/12/9/3268/pdf
article html file updated 4 May 2023 08:45 CEST Original file https://www.mdpi.com/2077-0383/12/9/3268/html
Back to TopTop